Declan Doogan serves as Executive at Biohaven Pharmaceutical Holding Co Ltd., where they oversee executive responsibilities. Since joining the company, Declan Doogan has executed 114 insider transactions totaling $64.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 18, 2018 involved selling 17,671 shares valued at $507.3K.
Declan Doogan currently holds 30,000 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Declan Doogan has been a net seller of BHVN stock. They have purchased $0 and sold $64.2M worth of shares.
Declan Doogan's most recent insider trade was on Jan 18, 2018, when they sold 17,671 shares at $28.71 per share.
Get notified when new Form 4 filings are submitted
| $29.22 |
| Discretionary |
| Jan 17, 2018 | BHVN | $1.0M | Sale | 37,530 | $26.84 | Discretionary |
| Jan 17, 2018 | BHVN | $621.4K | Sale | 23,726 | $26.19 | Discretionary |
| Jan 16, 2018 | BHVN | $984.7K | Sale | 37,033 | $26.59 | Discretionary |
| Jan 16, 2018 | BHVN | $49.6K | Sale | 1,834 | $27.07 | Discretionary |
| Jan 12, 2018 | BHVN | $356.2K | Sale | 13,599 | $26.19 | Discretionary |
| Jan 12, 2018 | BHVN | $526.4K | Sale | 19,843 | $26.53 | Discretionary |
| Jan 11, 2018 | BHVN | $1.2M | Sale | 46,746 | $26.27 | Discretionary |
| Jan 11, 2018 | BHVN | $37.3K | Sale | 1,392 | $26.77 | Discretionary |
| Jan 10, 2018 | BHVN | $3.0K | Sale | 100 | $29.98 | Discretionary |
| Jan 10, 2018 | BHVN | $647.6K | Sale | 23,869 | $27.13 | Discretionary |
| Jan 10, 2018 | BHVN | $76.2K | Sale | 2,600 | $29.31 | Discretionary |
| Jan 10, 2018 | BHVN | $390.9K | Sale | 13,793 | $28.34 | Discretionary |